Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sachin Sudhakar Wazalwar, Anita Ravindra Banpurkar & Franc Perdih. (2023) Synthesis, crystal structure and molecular docking study of novel isoxazole derivatives as CYP450 inhibitors in search of anticancer agents. Journal of Biomolecular Structure and Dynamics 41:19, pages 9476-9491.
Read now
Read now
Erika Cecchin, Elena De Mattia & Giuseppe Toffoli. (2016) Nuclear receptors and drug metabolism for the personalization of cancer therapy. Expert Opinion on Drug Metabolism & Toxicology 12:3, pages 291-306.
Read now
Read now
Amina I Shehu, Guangming Li, Wen Xie & Xiaochao Ma. (2016) The pregnane X receptor in tuberculosis therapeutics. Expert Opinion on Drug Metabolism & Toxicology 12:1, pages 21-30.
Read now
Read now
Articles from other publishers (29)
Sanaz Barzegar & Saeed Pirouzpanah. (2023)
Zinc finger proteins and
ATP
‐binding cassette transporter‐dependent multidrug resistance
. European Journal of Clinical Investigation.
Crossref
Crossref
Rebecca R. Florke Gee, Andrew D. Huber, Jing Wu, Richa Bajpai, Allister J. Loughran, Shondra M. Pruett-Miller & Taosheng Chen. (2023) The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation. Acta Pharmaceutica Sinica B 13:11, pages 4523-4534.
Crossref
Crossref
Gerardo Vázquez-Gómez, Jiří Petráš, Zdeněk Dvořák & Jan Vondráček. (2023) Aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) play both distinct and common roles in the regulation of colon homeostasis and intestinal carcinogenesis. Biochemical Pharmacology 216, pages 115797.
Crossref
Crossref
Yuan Liang, Yiyao Gong, Qiuyan Jiang, Yifan Yu & Jie Zhang. (2023) Environmental endocrine disruptors and pregnane X receptor action: A review. Food and Chemical Toxicology 179, pages 113976.
Crossref
Crossref
Stamatios Theocharis, Constantinos Giaginis, Stefania Gourzi, Paraskevi Alexandrou, Gerasimos Tsourouflis, Panagiotis Sarantis, Eugene Danas, Artemis Michail, Nikolaos Tsoukalas, Alexandros Pergaris, Panagiotis K. Politis & Lydia Nakopoulou. (2021) High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma. Diagnostics 11:11, pages 1946.
Crossref
Crossref
Aikaterini Skandalaki, Panagiotis Sarantis & Stamatios Theocharis. (2021) Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment. Biomolecules 11:8, pages 1142.
Crossref
Crossref
Dirk Theile & Pauline Wizgall. (2021) Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?. Naunyn-Schmiedeberg's Archives of Pharmacology 394:8, pages 1621-1632.
Crossref
Crossref
Bradley A. Creamer, Shelly N. B. Sloan, Jennifer F. Dennis, Robert Rogers, Sidney Spencer, Andrew McCuen, Purnadeo Persaud & Jeff L. Staudinger. (2020) Associations between Pregnane X Receptor and Breast Cancer Growth and Progression. Cells 9:10, pages 2295.
Crossref
Crossref
Tomohiro Nabekura, Tatsuya Kawasaki, Misuzu Jimura, Koichi Mizuno & Yuichi Uwai. (2020) Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein. Biochemistry and Biophysics Reports 21, pages 100727.
Crossref
Crossref
Juan Pablo Rigalli, Guillermo Nicolás Tocchetti & Johanna Weiss. (2019) Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects. Current Medicinal Chemistry 26:7, pages 1079-1112.
Crossref
Crossref
Bryan Mackowiak, Jessica Hodge, Sydney Stern & Hongbing Wang. (2018) The Roles of Xenobiotic Receptors: Beyond Chemical Disposition. Drug Metabolism and Disposition 46:9, pages 1361-1371.
Crossref
Crossref
Swetlana Gautam, Priyanka Singh, Manjari Singh, Subhadeep Roy, Jitendra K. Rawat, Rajnish K. Yadav, Uma Devi, Pushpraj S. Gupta, Shubhini A. Saraf & Gaurav Kaithwas. (2018) Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer. RSC Advances 8:7, pages 3512-3521.
Crossref
Crossref
Yan Dong, Zhe Wang, Gan-feng Xie, Chong Li, Wen-wei Zuo, Gang Meng, Cheng-ping Xu & Jian-jun Li. (2017) Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer. Molecular Cancer 16:1.
Crossref
Crossref
Peter O. Oladimeji, Wenwei Lin, C. Trent Brewer & Taosheng Chen. (2017) Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase. Scientific Reports 7:1.
Crossref
Crossref
Ping Zhang, Wentao Zhu, Dezhen Wang, Jin Yan, Yao Wang & Lin He. (2017) Enantioselective Effects of Metalaxyl Enantiomers on Breast Cancer Cells Metabolic Profiling Using HPLC-QTOF-Based Metabolomics. International Journal of Molecular Sciences 18:1, pages 142.
Crossref
Crossref
Elena De Mattia, Erika Cecchin, Rossana Roncato & Giuseppe Toffoli. (2016) Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine. Pharmacogenomics 17:14, pages 1547-1571.
Crossref
Crossref
Satyanarayana R. Pondugula, Petr Pavek & Sridhar Mani. (2016) Pregnane X Receptor and Cancer: Context-Specificity is Key. Nuclear Receptor Research 3.
Crossref
Crossref
Ioannis Koutsounas, Constantinos Giaginis, Paraskevi Alexandrou, Adamantia Zizi-Serbetzoglou, Efstratios Patsouris, Gregorios Kouraklis & Stamatios Theocharis. (2015) Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma. Pancreas 44:7, pages 1134-1140.
Crossref
Crossref
Salvador Alonso, Meng Su, Jace W. Jones, Sudipto Ganguly, Maureen A. Kane, Richard J. Jones & Gabriel Ghiaur. (2015) Human bone marrow niche chemoprotection mediated by cytochrome p450 enzymes. Oncotarget 6:17, pages 14905-14912.
Crossref
Crossref
Renata Silva, Vânia Vilas-Boas, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Félix Carvalho, Maria de Lourdes Bastos & Fernando Remião. (2015) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacology & Therapeutics 149, pages 1-123.
Crossref
Crossref
Wei Zhuo, Lei Hu, Jinfeng Lv, Hongbing Wang, Honghao Zhou & Lan Fan. (2014) Role of pregnane X receptor in chemotherapeutic treatment. Cancer Chemotherapy and Pharmacology 74:2, pages 217-227.
Crossref
Crossref
EN-QI QIAO & HONG-JIAN YANG. (2014) Effect of pregnane X receptor expression on drug resistance in breast cancer. Oncology Letters 7:4, pages 1191-1196.
Crossref
Crossref
ENQI QIAO, MINGHUA JI, JIANZHONG WU, RONG MA, XIAOHUA ZHANG, YUEJUN HE, QUANBIN ZHA, XUE SONG, LI-WEI ZHU & JINHAI TANG. (2013) Expression of the PXR gene in various types of cancer and drug resistance. Oncology Letters 5:4, pages 1093-1100.
Crossref
Crossref
Tingting Zhou, Shuyan Cong, Shiying Sun, Hongmiao Sun, Renlong Zou, Shengli Wang, Chunyu Wang, Jiao Jiao, Kiminobu Goto, Hajime Nawata, Toshihiko Yanase & Yue Zhao. (2013) Identification of endocrine disrupting chemicals activating SXR-mediated transactivation of CYP3A and CYP7A1. Molecular and Cellular Endocrinology 365:1, pages 36-43.
Crossref
Crossref
Satyanarayana R. Pondugula & Sridhar Mani. (2013) Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response. Cancer Letters 328:1, pages 1-9.
Crossref
Crossref
Yakun Chen, Yong Tang, Changxiong Guo, Jiuhui Wang, Debasish Boral & Daotai Nie. (2012) Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochemical Pharmacology 83:8, pages 1112-1126.
Crossref
Crossref
Laleh Amiri-Kordestani, Agnes Basseville, Karen Kurdziel, Antonio Tito Fojo & Susan E. Bates. (2012) Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resistance Updates 15:1-2, pages 50-61.
Crossref
Crossref
Ami Oguro, Koichi Sakamoto, Yoshihiko Funae & Susumu Imaoka. (2011) Overexpression of CYP3A4, but not of CYP2D6, Promotes Hypoxic Response and Cell Growth of Hep3B Cells. Drug Metabolism and Pharmacokinetics 26:4, pages 407-415.
Crossref
Crossref
Yakun Chen, Yong Tang, Gregory T. Robbins & Daotai Nie. (2010) Camptothecin Attenuates Cytochrome P450 3A4 Induction by Blocking the Activation of Human Pregnane X Receptor. Journal of Pharmacology and Experimental Therapeutics 334:3, pages 999-1008.
Crossref
Crossref